drugset / Trial / NCT07114848

Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.

NCT07114848

Phase 4 Completed 60 enrolled Liaquat National Hospital & Medical College
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the effects of two medications-tamsulosin and solifenacin-on symptoms associated with double J (DJ) ureteral stents. The research is conducted among patients undergoing unilateral DJ stent placement for ureteric calculi or post-ureteroscopic lithotripsy. Participants are randomly assigned to receive either tamsulosin or solifenacin, and symptom severity is assessed using the Ureteral Stent Symptom Questionnaire (USSQ).

Timeline

Start
2024-06-13
Primary completion
2024-12-30
Completion
2025-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solifenacin Small molecule 5 mg
Comparator Tamsulosin Other / unclassified 0.4 mg

Indications